Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveSaturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidenceTrans fatty acids: effects on cardiometabolic health and implications for policyMyocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesisCardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) StudyCardiovascular comorbidity in rheumatic diseases: a focus on heart failureThe role of oxidative stress and inflammation in cardiovascular agingEffect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A ReviewDonor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory ResponseHeart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiologyThe paradox of bardoxolone methyl: a call for every witness on the stand?Relation of anti- to pro-inflammatory cytokine ratios with acute myocardial infarction.Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure.The influence of pericardial fat upon left ventricular function in obese females: evidence of a site-specific effect.Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis.Income, education, and inflammation: differential associations in a national probability sample (The MIDUS study)Association between inflammatory biomarkers and bone mineral density in a community-based cohort of men and womenPredictors of interleukin-6 elevation in older adults.Molecular determinants of the cardiometabolic phenotype.Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise trainingInformation encoded in a network of inflammation proteins predicts clinical outcome after myocardial infarctionSerum iron concentration, but not hemoglobin, correlates with TIMI risk score and 6-month left ventricular performance after primary angioplasty for acute myocardial infarction.C-reactive Protein as a Predictor of Adverse outcome in Patients with Acute Coronary Syndrome.Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population.Social relationships, sleep quality, and interleukin-6 in aging women.Multimarker approach for the prediction of heart failure incidence in the communityIntermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults.Healthy lifestyle and decreasing risk of heart failure in women: the Women's Health Initiative observational study.Whole blood gene expression and interleukin-6 levels.Inflammatory markers in population studies of aging.Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.Left ventricular mass in dialysis patients, determinants and relation with outcome. Results from the COnvective TRansport STudy (CONTRAST).Management of cardiovascular risk factors in adults with congenital heart disease.Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study.White blood cell count, C-reactive protein, and incident heart failure in the Atherosclerosis Risk in Communities (ARIC) StudyManaging chemotherapy-related cardiotoxicity in survivors of childhood cancers.Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring CohortRole of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure.
P2860
Q24594814-472511F5-F40D-4670-BD16-A617DD63F851Q24634414-396D78A2-CAF9-46C8-BD67-B5C915A9B6F2Q24654965-62772FBC-8DD4-4DB8-8B38-5347F500721BQ24812557-2E600364-E16C-4605-8B55-94AE0813B21DQ24814820-3DF31A5F-A651-4560-B838-1BE91533441AQ26823443-D3ECBBDB-C2B1-44FC-BEFA-16FC627E6D0AQ26864987-E6B2DAEC-69DD-4D28-BC72-7FFB374DC019Q27023183-F2F55419-C4DF-43D4-BAA0-E81487AB7FBCQ29304005-D590AF59-8A1A-4E54-8E4D-6DFB70F17B0EQ30483582-5568D7C5-BE54-45CD-B603-03469326A135Q33358784-09F6F1D8-9E27-40AB-B33B-FEEDEFC6AFA0Q33691606-DADD93E3-66E2-4DA8-8E5C-79CA69203984Q33707885-69986B89-E14E-4745-8630-C96874847B2EQ33710663-3F44EC0A-0F04-4908-BB1E-A1A74602CFF4Q33713288-4CC02E06-476B-44C8-B2F3-03F21B395A42Q33764598-181F09D3-0551-49DB-9F05-A4ECCF786A7CQ33793994-A818C74C-A348-4E9B-B922-41C509B1634BQ33800888-9144A4A7-2A79-4F93-9ED8-5609BBE8B062Q33814110-6304E165-0003-4B34-AB90-1D75730BF7C5Q33921392-2C52E666-86B9-4B3E-9E8C-D6A1F12E6393Q33938878-9AFBE463-3D2F-4D85-94EA-1FC1237434DCQ33960753-9950F75B-EC6D-4A08-AA7F-1DEC57998F0BQ34011257-9977C1FA-83DD-4CAB-A4B2-4F14F0A08882Q34032614-F0D9A7FF-139F-496C-8981-85440E61CBCAQ34103605-AC03FB3F-A190-49D9-A4FB-543D0AF63FEFQ34234788-8C5370B3-3328-4F46-A435-8B32F39917CCQ34357369-0C27F7E7-769B-464F-BD70-38C14E2EF95CQ34490627-F80B0A1E-C478-4598-966E-E0A9FE5C2D3AQ34627340-F31343E6-5C05-4DF7-AA8C-73723F670F07Q34674343-EE867427-446D-4EE9-A90F-C9721FEF7C92Q34995451-E4A25706-09F3-40DF-BCBE-919426D5329EQ35026270-79EA449F-5834-4DF6-97C1-D99BD4BF487AQ35088034-E99833DE-61AA-4591-AB4D-BF527A464F13Q35114893-339C178D-FACA-43C6-B8A1-A56FCAFEFDFEQ35157562-6257E803-6453-4307-802C-9117F481FE75Q35194633-C41E8DB4-A8B1-428F-B1A0-B6E20E50EBD2Q35562745-752C70BF-E84F-4407-B79B-D86E72E674FFQ35572566-7DDEBF2C-83A8-4C58-B67A-285CDEF5C709Q35581462-64473CAF-F6D4-4E35-BE01-DBB8168E2EBFQ35583476-9AEA3A3C-A113-482B-8051-C913DC46B854
P2860
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Inflammatory markers and risk ...... n: the Framingham Heart Study.
@en
Inflammatory markers and risk ...... n: the Framingham Heart Study.
@nl
type
label
Inflammatory markers and risk ...... n: the Framingham Heart Study.
@en
Inflammatory markers and risk ...... n: the Framingham Heart Study.
@nl
prefLabel
Inflammatory markers and risk ...... n: the Framingham Heart Study.
@en
Inflammatory markers and risk ...... n: the Framingham Heart Study.
@nl
P2093
P50
P1433
P1476
Inflammatory markers and risk ...... n: the Framingham Heart Study.
@en
P2093
Daniel Levy
Douglas B Sawyer
Framingham Heart Study
Peter W F Wilson
Ralph B D'Agostino
P304
P356
10.1161/01.CIR.0000057810.48709.F6
P407
P50
P577
2003-03-01T00:00:00Z